Author:
Wang Ji-Guang,Sun Ning-Ling,Ke Yuan-Nan,Zhang Bo-Heng,Ikegami Naotaka,Zhu Jun-Ren
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference14 articles.
1. Zhu JR, Cai NS, Fan WH, Zhu DL, He B, Wu ZG, Ke YN, Guo JX, Ma H, Huang J, Li XL, Chen YZ. Efficacy and safety of olmesartan medoxomil versus losartan potassium in Chinese patients with mild to moderate essential hypertension. Chin J Cardiol (in Chinese). 2006;34:877–81.
2. Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J. Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. J Clin Hypertens (Greenwich). 2001;3(283–91):318.
3. Brunner HR, Stumpe KO, Januszewicz A. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertension. Clin Drug Investig. 2003;23:419–30.
4. Smith DH, Dubiel R, Jones M. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan. Am J Cardiovasc Drugs. 2005;5:41–50.
5. Fabia MJ, Abdilla N, Oltra R, Fernandez C, Redon J. Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens. 2007;25:1327–36.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献